Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
237
-
Total 13F shares, excl. options
-
44.4M
-
Shares change
-
+227K
-
Total reported value, excl. options
-
$1.61B
-
Value change
-
-$404K
-
Number of buys
-
97
-
Number of sells
-
-99
-
Price
-
$36.37
Significant Holders of AVANOS MEDICAL, INC. - Common Stock (AVNS) as of Q2 2021
281 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock as of Q2 2021.
AVANOS MEDICAL, INC. - Common Stock (AVNS) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.4M shares
of 46.1M outstanding shares and own 96.23% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.37M shares), VANGUARD GROUP INC (5.1M shares), WELLINGTON MANAGEMENT GROUP LLP (3.71M shares), Champlain Investment Partners, LLC (2.61M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.48M shares), Paradice Investment Management LLC (2.44M shares), DIMENSIONAL FUND ADVISORS LP (2.38M shares), RGM Capital, LLC (2.16M shares), STATE STREET CORP (1.79M shares), and MACQUARIE GROUP LTD (1.65M shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.